CCKAR Genotype

You inherited two copies of a gene called CCKAR (cholecystokinin A receptor), one from each parent, and the specific letters you carry shape how a receptor in your gut and brain responds to a hormone called cholecystokinin. That hormone helps your gallbladder contract, your pancreas release digestive enzymes, your brain register fullness, and certain mood and memory circuits function.

This test reads the letters at specific spots in your CCKAR gene. The result is permanent and does not change with diet, weight, or age. What it gives you is a stable piece of context for thinking about gallstone risk, irritable bowel patterns, and certain neuropsychiatric associations that other lab work cannot reveal.

What CCKAR Does in Your Body

CCKAR is a receptor that sits on the surface of cells in your small intestine, pancreas, gallbladder, and brain. It belongs to a family of proteins called G-protein-coupled receptors, which are signal switches that turn on internal cell activity when a hormone docks with them. When cholecystokinin, released by hormone-producing cells in the upper small intestine after a meal, binds CCKAR, it triggers gallbladder contraction, pancreatic enzyme release, slower stomach emptying, and a feeling of fullness.

In the brain, CCKAR sits on neurons that influence how nerve cells strengthen their connections over time, a process behind learning and memory. The same receptor system also touches mood, panic, and how your brain organizes language. Small letter changes in the gene can shift how well the receptor responds, which is why specific variants have been linked to gallstone disease, certain irritable bowel patterns, and brain-related traits.

Gallstone and Gallbladder Disease Risk

One of the clearest links is to gallstones. In a study of people in India, those carrying a specific CCKAR variant called the A1A1 genotype appeared more often among gallstone patients than among healthy controls, and the genotype behaved as an independent risk factor for gallstones. The same study did not find that this genotype changed gallbladder cancer risk.

A larger population study in Shanghai of women found a separate CCKAR variant, called rs1800855 AA, was associated with higher gallbladder cancer risk. Certain combinations of CCKAR letters appeared protective in the same study. These signals are sex-specific and population-specific, which means the meaning of any one variant depends on who is being studied.

Irritable Bowel Syndrome

In a small Korean study of 80 people with irritable bowel syndrome (IBS) and 76 controls, a CCKAR variant in a non-coding section of the gene, called intron 1 779 T greater than C, showed up more often in people with the constipation-predominant and mixed forms of IBS than in people without IBS. This suggests the receptor that governs gut motility may be tuned slightly differently in those whose gut behavior tilts toward constipation or mixed patterns, though the modest sample size means the finding should be treated as preliminary.

Schizophrenia and Brain Lateralization

In a study of more than 2,000 people, a CCKAR variant called rs1800857 (also written as IVS1-5T greater than C) was linked to schizophrenia risk in men. Men with one copy of the C version had roughly 1.7 times the odds of schizophrenia, and men with two copies had roughly 3.2 times the odds. The same variant did not show this signal in women, and the variant did not appear to change the amount of receptor protein cells made.

The same rs1800857 C variant was also linked to a reduction in the usual left-side brain dominance for language, measured by a listening task. Genetic variation in CCKAR explained about 3.7% of the differences in that brain dominance pattern, which is small but detectable. The variant did not change whether someone was right or left handed.

Panic, Hallucinations, and Other Brain Traits

A family-based study found some signal that CCKAR variants associate with panic, particularly when panic occurs alongside bipolar disorder, though the related gene CCKBR (cholecystokinin B receptor) showed stronger signals for panic in general. A separate study of panic disorder identified a new CCKAR variant but found no association with panic itself.

In Parkinson's disease, CCK and CCKAR variants previously linked to hallucinations in Japanese and Chinese populations showed only a weak, non-significant trend in a study of white patients, with the T allele appearing somewhat more often in those with hallucinations (P = .06) and four of five carriers of both CCK T and CCKAR C alleles being hallucinators. The study was underpowered because the relevant allele is less common in white populations, so the finding is best read as an unconfirmed signal rather than a clean negative. The broader point still stands: a variant's clinical meaning is tied to ancestry, and a result that carries weight in one population may not in another.

Why This Marker Sits in Research, Not Routine Care

CCKAR genotype is an exploratory research marker. There are no standardized clinical cutpoints, no guideline-driven testing programs, and no validated diagnostic performance numbers for using CCKAR variants to predict disease. The associations that exist are modest in size, often confined to one sex or one ancestry group, and many still need to be reproduced in larger and more diverse studies. Treat your result as one piece of background context, not a verdict.

Reconciling Mixed Findings

You will notice that different variants point in different directions across different conditions, and a variant linked to gallstones is not the same one linked to schizophrenia risk in men. That is expected. CCKAR shapes how a receptor functions across many tissues, and a single letter change can nudge gut motility in one direction and a brain signaling pathway in another. Think of your CCKAR result as a profile of small biases across several systems, not as a single number that gets better or worse.

One-Time Result

This is a once-in-a-lifetime test. The letters of your CCKAR gene were set at conception and do not change, so retesting the same variants gives the same answer. The value of this result comes from integrating it into ongoing decisions over years: how seriously you take gallbladder symptoms, how closely you watch IBS patterns, whether you mention a family history of schizophrenia or panic to your clinicians. If your downstream health changes, the right move is to track the relevant phenotype with the right tool, such as imaging for gallstones or symptom diaries for IBS, not to retest the genotype.

When Results Can Be Misleading

• Variant panel coverage: the test only reads the specific CCKAR variants it is designed to detect, so a result that does not flag risk does not rule out other rare variants in the same gene.
• Ancestry-specific meaning: several CCKAR associations were found in one population (for example, Japanese, Chinese, Indian, or Korean cohorts) and did not replicate in others, so the clinical weight of a result depends on your ancestry.
• Variant of uncertain significance: an unusual letter at a CCKAR position may be reported without a clear interpretation, because the science behind it is still maturing.
• Clinical-grade vs direct-to-consumer: results from a consumer ancestry service that touches CCKAR are not equivalent to a clinical-grade assay and should not be used to drive medical decisions.

What to Do With an Unexpected Result

If your CCKAR result flags a variant linked to one of the documented associations, treat that as a prompt to monitor the relevant phenotype more carefully, not as a diagnosis. For a gallstone-linked variant, that means paying attention to upper-right abdominal symptoms after fatty meals and discussing imaging if symptoms arise. For an IBS-associated variant, that means tracking bowel patterns and considering a gastroenterology evaluation if symptoms persist. For a schizophrenia or panic-linked variant, especially with a relevant family history, that means a conversation with a mental health clinician about early warning signs. A genetic counselor can help you place the result in the context of your family history and ancestry. Biological family members may want to know what you carry, since they share a portion of your genetics, though carrying a risk variant does not mean a disease will develop.